TY - JOUR T1 - Metabolic Imaging in Parkinson Disease JF - Journal of Nuclear Medicine JO - J Nucl Med SP - 23 LP - 28 DO - 10.2967/jnumed.116.183152 VL - 58 IS - 1 AU - Sanne K. Meles AU - Laura K. Teune AU - Bauke M. de Jong AU - Rudi A. Dierckx AU - Klaus L. Leenders Y1 - 2017/01/01 UR - http://jnm.snmjournals.org/content/58/1/23.abstract N2 - This review focuses on recent human 18F-FDG PET studies in Parkinson disease. First, an overview is given of the current analytic approaches to metabolic brain imaging data. Next, we discuss how 18F-FDG PET studies have advanced understanding of the relation between distinct brain regions and associated symptoms in Parkinson disease, including cognitive decline. In addition, the value of 18F-FDG PET studies in differential diagnosis, identifying prodromal patients, and the evaluation of treatment effects are reviewed. Finally, anticipated developments in the field are addressed. ER -